Första AP-fonden’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,700
Closed -$2.63M 595
2022
Q3
$2.63M Sell
10,700
-1,300
-11% -$351K 0.03% 473
2022
Q2
$2.97M Sell
12,000
-200
-2% -$54K 0.04% 452
2022
Q1
$4.04M Sell
12,200
-1,800
-13% -$554K 0.05% 422
2021
Q4
$5.03M Buy
14,000
+3,200
+30% +$1.08M 0.05% 402
2021
Q3
$3.52M Buy
+10,800
New +$3.66M 0.04% 450
2021
Q1
Sell
-8,600
Closed -$2.79M 563
2020
Q4
$2.79M Buy
8,600
+2,000
+30% +$553K 0.04% 445
2020
Q3
$1.83M Buy
6,600
+700
+12% +$202K 0.04% 444
2020
Q2
$1.43M Buy
+5,900
New +$1.18M 0.04% 455

Other funds holding ABMD

Första AP-fonden's ABMD Position: Q4 2022 in Review

Första AP-fonden sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 10,700 shares — an estimated $2.63M sold.

Första AP-fonden first reported a position in ABMD in Q2 2020 and held it in 8 quarters. The position peaked at $5.03M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Första AP-fonden reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Första AP-fonden sold 10,700 Abiomed Inc shares in Q4 2022, an estimated $2.63M.
  • Första AP-fonden first reported a position in Abiomed Inc in Q2 2020 and held it in 8 quarters.
  • Första AP-fonden's Abiomed Inc position peaked at $5.03M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Första AP-fonden's 13F filing for Q4 2022, filed 2 Feb 2023.